Role of interleukin-8 secreted from human oral squamous cell carcinoma cell lines

被引:85
作者
Watanabe, H [1 ]
Iwase, M [1 ]
Ohashi, M [1 ]
Nagumo, M [1 ]
机构
[1] Showa Univ, Sch Dent, Dept Oral & Maxillofacial Surg 2, Tokyo 1458515, Japan
来源
ORAL ONCOLOGY | 2002年 / 38卷 / 07期
关键词
squamous cell carcinoma; interleukin-8; migration; invasion; matrix metalloproteinase;
D O I
10.1016/S1368-8375(02)00006-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Interleukin-8 (IL-8) is an important cytokine involved in tumor growth and angiogenesis in a variety of malignancies. Furthermore, matrix metalloptoteinases (MMPs) also play important roles in the invasion and metastasis of carcinomas including oral squamous cell carcinoma (OSCC). We studied whether IL-8 and MMPs participate in tumorigenesis and metastasis of OSCC. First, we investigated the gene and protein expressions of IL-8 and IL-8 receptor (IL-8R), and the effect of IL-8 on proliferation, migration and invasion of OSCC. Second, we thus also investigated the effect of IL-8 on MMP release in OSCC cells. OSCC cell lines NA and HSC-4 constitutively expressed IL-8 mRNA and secreted its protein in vitro. The production of IL-8 was significantly enhanced by the addition of tumor necrosis factor (TNF)-alpha. and IL-beta, but not interferon (IFN)-gamma, granulocyte-macrophage colony-stimulating factor (GM-CSF) or IL-2. Flow cytometric analysis revealed the constitutive expression of both receptors of IL-8, IL-8RA and IL-8RB, in OSCC cell lines. The expression of IL-8 receptors in HSC-4 cells was stronger than that in NA cells. The intensity of IL-8RA expression was stronger than that of IL-8RB expression in each cell line. The expression of IL-8 receptors was not altered by the addition of cytokines such as TNF-alpha and IL-1beta. The conditioned medium containing IL-8 from OSCC cell lines induced migration and invasion of OSCC cells, but did not change cell proliferation. The differences in migrational and invasive ability between NA cells and HSC-4 cells were correlated with the expression intensity of IL-8 receptors in each cell line. Neutralizing antibodies to IL-8, IL-8RA and IL-8RB partially inhibited the chemotactic activity induced by conditioned medium. The expression of MMP-2, -7 and -9 was detected in culture supernatants from these OSCC cell lines. The expressions of MMP-7 protein and mRNA were enhanced by the addition of rIL-8, but that of other MMPs was not observed in a similar manner. These results suggest that IL-8 secreted from OSCC may contribute to the invasion of OSCC through the regulation of MMP-7 expression. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:670 / 679
页数:10
相关论文
共 45 条
[1]  
ABRUZZO LV, 1992, AM J PATHOL, V140, P365
[2]   Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer [J].
Arenberg, DA ;
Keane, MP ;
DiGiovine, B ;
Kunkel, SL ;
Morris, SB ;
Xue, YY ;
Burdick, MD ;
Glass, MC ;
Iannettoni, MD ;
Strieter, RM .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (03) :465-472
[3]   Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice [J].
Arenberg, DA ;
Kunkel, SL ;
Polverini, PJ ;
Glass, M ;
Burdick, MD ;
Strieter, RM .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (12) :2792-2802
[4]   Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro [J].
Brew, R ;
Erikson, JS ;
West, DC ;
Kinsella, AR ;
Slavin, J ;
Christmas, SE .
CYTOKINE, 2000, 12 (01) :78-85
[5]  
Chen Z, 1999, CLIN CANCER RES, V5, P1369
[6]  
CHOEN RF, 1995, ARCH OTOLARYNGOL, V121, P202
[7]  
CHUNTHARAPAI A, 1995, J IMMUNOL, V155, P2587
[8]   Paclitaxel up-regulates interleukin-8 synthesis in human lung carcinoma through an NF-κB- and AP-1-dependent mechanism [J].
Collins, TS ;
Lee, LF ;
Ting, JPY .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 49 (02) :78-84
[9]  
Fujimoto J, 2000, CANCER RES, V60, P2632
[10]   α-Chemokine growth factors for adenocarcinomas;: a synthetic peptide inhibitor for α-chemokines inhibits the growth of adenocarcinoma cell lines [J].
Fujisawa, N ;
Sakao, Y ;
Hayashi, S ;
Hadden, WA ;
Harmon, CL ;
Miller, EJ .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (01) :19-26